For citations:
Kasyanenko K.V., Maltsev O.V., Kozlov K.V., Lapikov I.I., Lvov N.I., Sukachev V.S., Zhdanov K.V., Sorokin P.V., Ratnikova A.K. Clinical Efficiency and Safety of Riamilovir for Treating Patients with SARS-CoV-2 Infection. Antibiot Khimioter = Antibiotics and Chemotherapy. 2020;65(11-12):16-21. (In Russ.) https://doi.org/10.37489/0235-2990-2020-65-11-12-16-21
Email this article 